Pharmacokinetics of [6]-shogaol, a pungent ingredient of Zingiber officinale Roscoe (Part I)
Authors:
- 19 March 2010
- journal article
- research article
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 64 (3) , 281-287
Abstract
To investigate the pharmacokinetics of [6]-shogaol, a pungent ingredient of Zingiber officinale Roscoe, the pharmacokinetic parameters were determined by using 14C-[6]-shogaol (labeled compound) and [6]-shogaol (non-labeled compound). When the labeled compound was orally administered to rats, the maximum plasma concentration (C max) and the area under the curve (AUC) of plasma radioactivity concentration increased in a dose-dependent manner. When the labeled compound was orally administered at a dose of 10 mg/kg, 20.0 ± 1.8% of the radioactivity administered was excreted into urine, 64.0 ± 12.9% into feces, and 0.2 ± 0.1% into breath. Thus, more of the radioactivity was excreted into feces than into urine, and almost no radioactivity was excreted into breath. Furthermore, when the labeled compound was orally administered at a dose of 10 mg/kg, cumulative biliary radioactivity excretion over 48 h was 78.5 ± 4.5% of the radioactivity administered, and cumulative urinary radioactivity excretion over 48 h was 11.8 ± 2.7%, showing that about 90% of the dose administered orally was absorbed from the digestive tract and most of the fecal excretion was via biliary excretion. On the other hand, when the non-labeled compound [6]-shogaol was orally administered, the plasma concentration and biliary excretion of the unchanged form were extremely low. When these results are combined with those obtained with the labeled compound, it would suggest that [6]-shogaol is mostly metabolized in the body and excreted as metabolites.Keywords
This publication has 16 references indexed in Scilit:
- Pharmacokinetics of 6-Gingerol, 8-Gingerol, 10-Gingerol, and 6-Shogaol and Conjugate Metabolites in Healthy Human SubjectsCancer Epidemiology, Biomarkers & Prevention, 2008
- Stability of [6]-gingerol and [6]-shogaol in simulated gastric and intestinal fluidsJournal of Pharmaceutical and Biomedical Analysis, 2007
- Microsomal Hydroxylation and Glucuronidation of [6]-GingerolJournal of Agricultural and Food Chemistry, 2006
- Characterization of gingerol‐related compounds in ginger rhizome ( Zingiber officinale Rosc.) by high‐performance liquid chromatography/electrospray ionization mass spectrometryRapid Communications in Mass Spectrometry, 2005
- Commercially processed dry ginger (Zingiber officinale): Composition and effects on LPS-stimulated PGE2 productionPhytochemistry, 2005
- Component ofZingiber officinalethat Improves the Enhancement of Small Intestinal TransportPlanta Medica, 2002
- Pharmacological Evaluation of Shokyo and Kankyo. (1).Biological and Pharmaceutical Bulletin, 2002
- Pharmacokinetics of (6)-Gingerol after Intravenous Administration in Rats with Acute Renal or Hepatic Failure.Chemical and Pharmaceutical Bulletin, 1992
- Pharmacokinetics of (6)-Gingerol after Intravenous Administration in Rats.Chemical and Pharmaceutical Bulletin, 1991
- Pharmacological studies on ginger. IV Effect of (6)-shogaol on the arachidonic cascade.Folia Pharmacologica Japonica, 1986